川芎嗪、丹参酮ⅡA对PG干细胞样细胞凋亡的影响

被引:2
作者
王耀焓
张培彤
杨栋
韩海英
郭秀伟
祁鑫
张芸
机构
[1] 中国中医科学院广安门医院肿瘤科
关键词
肿瘤干细胞; 凋亡; 川芎嗪; 丹参酮ⅡA;
D O I
10.13192/j.issn.1000-1719.2016.05.045
中图分类号
R285 [中药药理学];
学科分类号
100806 [中药药理学];
摘要
目的:观察不同剂量川芎嗪、丹参酮ⅡA对干细胞样细胞凋亡的影响。方法:将无血清培养获得的球细胞随机分为7组,依次为对照组、低剂量川芎嗪组、中剂量川芎嗪组、高剂量川芎嗪组、低剂量丹参酮ⅡA组、中剂量丹参酮ⅡA组、高剂量丹参酮ⅡA组,应用流式细胞术分别检测PG-BE1、PG-LH7细胞凋亡。结果:PG-BE1细胞系中剂量川芎嗪及不同浓度丹参酮ⅡA均可促进PG-BE1干细胞样细胞凋亡,其中高剂量丹参酮ⅡA促凋亡作用最强,其余三组之间促凋亡能力无统计学差异;PG-LH71细胞系低、高浓度川芎嗪、丹参酮ⅡA对PG干细胞样细胞均有促凋亡作用,其中高剂量丹参酮ⅡA促凋亡能力最强,低剂量川芎嗪促凋亡能力最弱。结论:无论是PG-BE1细胞系还是PG-LH7细胞系,高剂量丹参酮ⅡA均可明显促进PG干细胞样细胞的凋亡,其促凋亡能力等于或大于顺铂促凋亡能力。
引用
收藏
页码:1024 / 1028+4 +4-5
页数:7
相关论文
共 10 条
[1]
Topoisomerase I inhibitors; shikonin and topotecan; inhibit growth and induce apoptosis of glioma cells and glioma stem cells..[J].Feng-Lei Zhang;Ping Wang;Yun-Hui Liu;Li-Bo Liu;Xiao-Bai Liu;Zhen Li;Yi-Xue Xue.PLoS ONE.2017, 11
[2]
Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo [J].
Chiu, S. C. ;
Huang, S. Y. ;
Chen, S. P. ;
Su, C. C. ;
Chiu, T. L. ;
Pang, C. Y. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2013, 16 (04) :315-322
[3]
Proteomic analysis reveals tanshinone IIA enhances apoptosis of advanced cervix carcinoma C a S ki cells through mitochondria intrinsic and endoplasmic reticulum stress pathways.[J].Tai‐Long Pan;Pei‐Wen Wang;Yu‐Chiang Hung;Chun‐Hsun Huang;Kun‐Ming Rau.Proteomics.2013, 23-2
[4]
Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction [J].
Wang, Li ;
Guo, Huijie ;
Yang, Liuqi ;
Dong, Lihua ;
Lin, Caiyu ;
Zhang, Jie ;
Lin, Ping ;
Wang, Xiujie .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2013, 379 (1-2) :7-18
[5]
Morusin inhibits human cervical cancer stem cell growth and migration through attenuation of NF-κB activity and apoptosis induction [J].
Li Wang ;
Huijie Guo ;
Liuqi Yang ;
Lihua Dong ;
Caiyu Lin ;
Jie Zhang ;
Ping Lin ;
Xiujie Wang .
Molecular and Cellular Biochemistry, 2013, 379 :7-18
[6]
Survivin is highly expressed in CD34+38- leukemic stem/progenitor cells and predicts poor clinical outcomes in AML [J].
Carter, Bing Z. ;
Qiu, Yihua ;
Huang, Xuelin ;
Diao, Lixia ;
Zhang, Nianxiang ;
Coombes, Kevin R. ;
Mak, Duncan H. ;
Konopleva, Marina ;
Cortes, Jorge ;
Kantarjian, Hagop M. ;
Mills, Gordon B. ;
Andreeff, Michael ;
Kornblau, Steven M. .
BLOOD, 2012, 120 (01) :173-180
[7]
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase [J].
Pandey, Puspa R. ;
Okuda, Hiroshi ;
Watabe, Misako ;
Pai, Sudha K. ;
Liu, Wen ;
Kobayashi, Aya ;
Xing, Fei ;
Fukuda, Koji ;
Hirota, Shigeru ;
Sugai, Tamotsu ;
Wakabayashi, Go ;
Koeda, Keisuke ;
Kashiwaba, Masahiro ;
Suzuki, Kazuyuki ;
Chiba, Toshimi ;
Endo, Masaki ;
Fujioka, Tomoaki ;
Tanji, Susumu ;
Mo, Yin-Yuan ;
Cao, Deliang ;
Wilber, Andrew C. ;
Watabe, Kounosuke .
BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (02) :387-398
[8]
Targeting apoptosis pathways in cancer stem cells.[J].Michele Signore;Lucia Ricci-Vitiani;Ruggero De Maria.Cancer Letters.2011,
[9]
Targeting breast stem cells with the cancer preventive compounds curcumin and piperine [J].
Kakarala, Madhuri ;
Brenner, Dean E. ;
Korkaya, Hasan ;
Cheng, Connie ;
Tazi, Karim ;
Ginestier, Christophe ;
Liu, Suling ;
Dontu, Gabriela ;
Wicha, Max S. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (03) :777-785
[10]
Comparison between cells and cancer stem-like cells isolated from glioblastoma and astrocytoma on expression of anti-apoptotic and multidrug resistance–associated protein genes.[J].F. Jin;L. Zhao;H.-Y. Zhao;S.-G. Guo;J. Feng;X.-B. Jiang;S.-L. Zhang;Y.-J. Wei;R. Fu;J.-S. Zhao.Neuroscience.2008, 2